Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock Net Income 2021–2025
Amylyx Pharmaceuticals, Inc. Common Stock annual/quarterly net income history and growth rate from 2021 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Amylyx Pharmaceuticals, Inc. Common Stock net income for the quarter ending September 30, 2025 was -34.4 M, a 52.70% decrease year-over-year.
- Amylyx Pharmaceuticals, Inc. Common Stock net income for the twelve months ending September 30, 2025 was -184.4 M, a 24.18% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. Common Stock annual net income for 2025 was -144.7 M, a 52.03% decrease from 2024.
- Amylyx Pharmaceuticals, Inc. Common Stock annual net income for 2024 was -301.7 M, a 712.42% decrease from 2023.
- Amylyx Pharmaceuticals, Inc. Common Stock annual net income for 2023 was 49.3 M, a 124.84% decrease from 2022.
- Amylyx Pharmaceuticals, Inc. Common Stock annual net income for 2022 was -198.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amylyx Pharmaceuticals, Inc. Common Stock Net Income — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) net income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Amylyx Pharmaceuticals, Inc. Common Stock's net income?
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) reported net income of -$145M for fiscal 2025.
Where can I see AMLX's net income history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's net income by year and by quarter, including the growth rate.